Page 146 - 《中国药房》2025年19期
P. 146

[11]  SUN Y Y,ZHU H J,ZHAO R Y,et al. Remote ischemic   [25]  DENG  Z Y,SUN  M  M,WU  J,et  al.  SIRT1  attenuates
               conditioning attenuates oxidative stress and inflammation   sepsis-induced   acute   kidney   injury   via   Beclin1
               via  the  Nrf2/HO-1  pathway  in  MCAO  mice[J].  Redox   deacetylation-mediated  autophagy  activation[J].  Cell
               Biol,2023,66:102852.                                Death Dis,2021,12(2):217.
          [12]  FU Z J,WANG Z Y,XU L,et al. HIF-1α-BNIP3-media-   [26]  ZHAO  M,WANG Y  Z,LI  L,et  al.  Mitochondrial  ROS
               ted mitophagy in tubular cells protects against renal ische-   promote  mitochondrial  dysfunction  and  inflammation  in
               mia/reperfusion injury[J]. Redox Biol,2020,36:101671.  ischemic  acute  kidney  injury  by  disrupting  TFAM-
          [13]  MOLEMA G,ZIJLSTRA J G,VAN MEURS M,et al. Re‐       mediated mtDNA maintenance[J]. Theranostics,2021,11
               nal  microvascular  endothelial  cell  responses  in  sepsis-  (4):1845-1863.
               induced acute kidney injury[J]. Nat Rev Nephrol,2022,18  [27]  WANG Y,ZHANG H Y,CHEN Q,et al. TNF-α/HMGB1
              (2):95-112.                                          inflammation  signalling  pathway  regulates  pyroptosis
          [14]  KRUIDERING  M,VAN  DE  WATER  B,DE  HEER  E,       during liver failure and acute kidney injury[J]. Cell Prolif,
               et  al.  Cisplatin-induced  nephrotoxicity  in  porcine  proxi‐  2020,53(6):e12829.
               mal tubular cells:mitochondrial dysfunction by inhibition   [28]  SATO Y,YANAGITA M. Immune cells and inflammation
               of complexes Ⅰ to Ⅳ of the respiratory chain[J]. J Phar‐  in  AKI  to  CKD  progression[J].  Am  J  Physiol  Renal
               macol Exp Ther,1997,280(2):638-649.                 Physiol,2018,315(6):F1501-F1512.
          [15]  YANG  S  K,HAN  Y  C,HE  J  R,et  al.  Mitochondria-  [29]  OECKINGHAUS A,HAYDEN  M  S,GHOSH  S.  Cross‐
               targeted  peptide  SS-31  prevents  cisplatin-induced  acute   talk in NF-κB signaling pathways[J]. Nat Immunol,2011,
               kidney  injury  via  regulating  mitochondrial  ROS-NLRP3   12(8):695-708.
               pathway[J]. Biomed Pharmacother,2020,130:110521.  [30]  YEUNG F,HOBERG J E,RAMSEY C S,et al. Modula‐
          [16]  WU J J,RONG S,ZHOU J,et al. The role and mecha‐    tion of NF-kappa B-dependent transcription and cell sur‐
               nism of PKM2 in the development of LPS-induced acute   vival  by  the  SIRT1  deacetylase[J].  EMBO  J,2004,23
               kidney injury[J]. Histol Histopathol,2021,36(8):845-852.  (12):2369-2380.
          [17]  KRUPA A,KRUPA M M,PAWLAK K. Indoleamine 2,3   [31]  ZHU Q,LI X H,CHEN H Y,et al. The effects of com‐
               dioxygenase 1-the potential link between the innate immu‐  pound Centella formula on oxinflammation and silent in‐
               nity and the ischemia-reperfusion-induced acute kidney in‐  formation  regulator  1  in  a  high-fat  diet/streptozotocin-
               jury [J]. Int J Mol Sci,2022,23(11):6176.           induced  diabetic  kidney  disease  rat  model[J].  Exp  Ther
          [18]  ZAHEDI K,BARONE S,SOLEIMANI M. Polyamine ca‐       Med,2021,22(3):962.
               tabolism in acute kidney injury[J]. Int J Mol Sci,2019,20  [32]  ZHU Q,ZENG J L,LI J,et al. Effects of compound Cen‐
              (19):4790.                                           tella  on  oxidative  stress  and  Keap1-Nrf2-ARE  pathway
          [19]  DECUYPERE  J  P,HUTCHINSON  S,MONBALIU  D,         expression in diabetic kidney disease rats[J]. Evid Based
               et al. Autophagy dynamics and modulation in a rat model   Complement Alternat Med,2020,2020:9817932.
               of  renal  ischemia-reperfusion  injury[J].  Int  J  Mol  Sci,  [33]  WEI Y F,ZHANG Y B,ZHAN B H,et al. Asiaticoside al‐
               2020,21(19):7185.                                   leviated NAFLD by activating Nrf2 and inhibiting the NF-
          [20]  JIANG  M,WEI  Q  Q,DONG  G  E,et  al. Autophagy  in   κB pathway[J]. Phytomedicine,2025,136:156317.
               proximal  tubules  protects  against  acute  kidney  injury[J].   [34]  李文 . 积雪草苷调控 SIRT1/NF-κB/NLRP3 通路介导抗
               Kidney Int,2012,82(12):1271-1283.                   炎作用改善肾缺血再灌注损伤的机制研究[D]. 郑州:河
          [21]  OUYANG X,HE Z M,FANG H,et al. A protein encoded    南中医药大学,2022.
               by circular ZNF609 RNA induces acute kidney injury by   [35]  TANG S J,XIE X C,WANG M,et al. Protective effects
               activating  the  AKT/mTOR-autophagy  pathway[J].  Mol   of asiaticoside on renal ischemia reperfusion injury in vivo
               Ther,2023,31(6):1722-1738.                          and in vitro[J]. Bioengineered,2022,13(4):10235-10243.
          [22]  ZHAO Y,FENG X J,LI B,et al. Dexmedetomidine pro‐  [36]  NI Y H,PAN Y X,ZHOU J,et al. Asiaticoside and asiatic
               tects  against  lipopolysaccharide-induced  acute  kidney  in‐  acid improve diabetic nephropathy by restoring podocyte
               jury  by  enhancing  autophagy  through  inhibition  of  the   autophagy and improving gut microbiota dysbiosis[J]. Bio‐
               PI3K/AKT/mTOR  pathway[J].  Front  Pharmacol,2020,  chem Pharmacol,2025,241:117161.
               11:128.                                        [37]  YANG C,GUO Y,HUANG T S,et al. Asiatic acid pro‐
          [23]  MEI S Q,LIVINGSTON M,HAO J L,et al. Autophagy is   tects against cisplatin-induced acute kidney injury via anti-
               activated to protect against endotoxic acute kidney injury  apoptosis  and  anti-inflammation[J].  Biomed  Pharmaco‐
               [J]. Sci Rep,2016,6:22171.                          ther,2018,107:1354-1362.
          [24]  ZHAO W Y,ZHANG L,CHEN R,et al. SIRT3 protects               (收稿日期:2025-04-16  修回日期:2025-08-18)
               against  acute  kidney  injury  via  AMPK/mTOR-regulated                           (编辑:胡晓霖)
               autophagy[J]. Front Physiol,2018,9:1526.



          · 2488 ·    China Pharmacy  2025 Vol. 36  No. 19                            中国药房  2025年第36卷第19期
   141   142   143   144   145   146   147   148